SCHEMBL11986330

SCHEMBL11986330

[1H][13C@]([2H])(C)[S+]([O-])c1cc(C)ccc1OC

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 1/20 0.43
ALDH1A1 P00352 3/20 0.40
CYP3A4 P08684 2/20 0.40
L3MBTL1 Q9Y468 8/20 0.36
MAPT P10636 8/20 0.36
HPGD P15428 5/20 0.36
MAPK1 P28482 3/20 0.36
POLB P06746 3/20 0.36
CYP2C9 P11712 3/20 0.36
CYP2C19 P33261 3/20 0.36
MEN1 O00255 1/20 0.36
USP2 O75604 1/20 0.36
ALOX12 P18054 1/20 0.36
KMT2A Q03164 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
KDM4E B2RXH2 2/20 0.35
TDP1 Q9NUW8 5/20 0.34
LMNA P02545 2/20 0.34
GAA P10253 2/20 0.34
TSHR P16473 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11986331 0.79 CA1 (0.40) ACHEALDH1A1L3MBTL1MAPK1TDP1
SCHEMBL11986333 0.74 CA2 (0.39) ACHEALDH1A1CYP3A4MAPTMAPK1
SCHEMBL11986338 0.74 CA2 (0.39) ACHEALDH1A1CYP3A4MAPTMAPK1
SCHEMBL11986335 0.73 SLC2A1 (0.34) ALDH1A1CYP3A4MAPTHPGDKDM4E
SCHEMBL11986316 0.66 IDO1 (0.33) HSD17B10
SCHEMBL11986350 0.66 KMT2A (0.51) L3MBTL1HPGDMAPK1POLBMEN1
SCHEMBL11986324 0.64 ACHE (0.39) ACHEALDH1A1CYP3A4LMNA
SCHEMBL3182131 0.64 ACHE (0.48) ACHEALDH1A1CYP3A4L3MBTL1MAPT
SCHEMBL8282401 0.63 ACHE (0.58) ACHEALDH1A1CYP3A4L3MBTL1MAPT
SCHEMBL29403877 0.62 ACHE (1.00) ACHEALDH1A1CYP3A4L3MBTL1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8247234-B2 Isotopically labeled compositions and method LOS ALAMOS NATIONAL SECURITY, LLC (US) 2012-08-21 US disclosed
US-20110269985-A1 ISOTOPICALLY LABELED COMPOSITIONS AND METHOD LOS ALAMOS NATIONAL SECURITY, LLC (US) 2011-11-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110269985-A1 ISOTOPICALLY LABELED COMPOSITIONS AND METHOD SRMS, NES, RPS27A ACHE 3811/4885ALDH1A1 3543/4885CYP3A4 967/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.